Back to Scanner
KYMR
NASDAQRS 34Score 35Kymera Therapeutics, Inc.
HealthcareBiotechnology$6.97B1 setup passing
$85.27
-0.2% ($0.13)
-17.2% from 52W High
P/E (TTM)
-23.10
Fwd P/E
—
PEG
—
Analyst Upside
+42.3%
EPS Growth
—
Gross Margin
100.0%
ROE
-29.1%
D/E
0.05
Div Yield
0.0%
Avg Volume
690.9K
Price Chart
Key Levels
SMA 200
$63.10
SMA 50
$81.07
Price
$85.27
52W High
$102.98
Target
$121.33
Setup Radar
1/8 passing📈
CAN SLIMO'Neil
Near highs + RS ≥ 80
🎯
VCPMinervini
Within 25% high, RS ≥ 70, > 200 SMA
📊
Trend TemplateMinervini
> 50 & 200 SMA, RS ≥ 70, near high
🚀
Stage 2Weinstein
RS ≥ 60, > 200 SMA
📦
Darvas BoxDarvas
Near highs, > 200 SMA
⚡
Earnings MomentumGrowth
EPS growth ≥ 20%
🔍
PEG HunterLynch
PEG < 1.5, EPS growth ≥ 15%
🎪
Analyst UpsideConsensus
Target upside ≥ 15%, 1+ analyst